Kiyonobu Ueno

791 total citations
38 papers, 575 citations indexed

About

Kiyonobu Ueno is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Kiyonobu Ueno has authored 38 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 9 papers in Epidemiology. Recurrent topics in Kiyonobu Ueno's work include Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Lung Cancer Research Studies (8 papers). Kiyonobu Ueno is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Lung Cancer Research Studies (8 papers). Kiyonobu Ueno collaborates with scholars based in Japan, United Kingdom and Uzbekistan. Kiyonobu Ueno's co-authors include Shigeto Hosoe, Tadamitsu Kishimoto, Fumio Imamura, Toru Kumagai, Mana Yoshimura, Yoko Kusunoki, Hiroyasu Yamamoto, Masashi Narazaki, Seijiro Minamoto and Junji Uchida and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Annals of Oncology.

In The Last Decade

Kiyonobu Ueno

32 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kiyonobu Ueno Japan 13 259 212 204 77 77 38 575
М. К. Ибрагимова Russia 13 217 0.8× 211 1.0× 99 0.5× 105 1.4× 69 0.9× 78 507
Pedro Molina-Sánchez Spain 8 127 0.5× 176 0.8× 144 0.7× 52 0.7× 117 1.5× 13 473
Gerd Leder Germany 11 287 1.1× 212 1.0× 55 0.3× 43 0.6× 93 1.2× 13 526
F. Lerebours France 13 437 1.7× 212 1.0× 90 0.4× 104 1.4× 57 0.7× 49 713
Marianna Scrima Italy 17 237 0.9× 640 3.0× 182 0.9× 82 1.1× 61 0.8× 30 890
Yongdong Jiang China 14 157 0.6× 308 1.5× 71 0.3× 27 0.4× 107 1.4× 25 571
Sangeetha M. Reddy United States 15 499 1.9× 256 1.2× 139 0.7× 77 1.0× 248 3.2× 29 830
Deborah Lehrer United States 11 240 0.9× 210 1.0× 91 0.4× 108 1.4× 117 1.5× 21 706
Kristin Padavic United States 9 205 0.8× 394 1.9× 68 0.3× 62 0.8× 178 2.3× 10 612
Steffen Wedel Germany 13 237 0.9× 489 2.3× 187 0.9× 42 0.5× 194 2.5× 22 722

Countries citing papers authored by Kiyonobu Ueno

Since Specialization
Citations

This map shows the geographic impact of Kiyonobu Ueno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiyonobu Ueno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiyonobu Ueno more than expected).

Fields of papers citing papers by Kiyonobu Ueno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiyonobu Ueno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiyonobu Ueno. The network helps show where Kiyonobu Ueno may publish in the future.

Co-authorship network of co-authors of Kiyonobu Ueno

This figure shows the co-authorship network connecting the top 25 collaborators of Kiyonobu Ueno. A scholar is included among the top collaborators of Kiyonobu Ueno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiyonobu Ueno. Kiyonobu Ueno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
5.
Matsumoto, Kinnosuke, Akihiro Tamiya, Yoshihiko Taniguchi, et al.. (2023). Sequencing strategies with ramucirumab and docetaxel following prior treatments for advanced non-small cell lung cancer: a multicenter retrospective cohort study. European Journal of Clinical Pharmacology. 79(4). 503–511. 4 indexed citations
6.
Kawada, Masahiro, et al.. (2022). Bilateral refractory pneumothorax treated by pleurodesis and bronchial occlusion in a COVID ‐19 patient. SHILAP Revista de lepidopterología. 10(12). e6754–e6754.
7.
Tamiya, Motohiro, Kei Fujikawa, Hidekazu Suzuki, et al.. (2022). Classification and regression tree for estimating predictive markers to detect T790M mutations after acquired resistance to first line EGFR-TKI: HOPE-002. Investigational New Drugs. 40(2). 361–369. 4 indexed citations
8.
Matsumoto, Kinnosuke, Akihiro Tamiya, Yuji Inagaki, et al.. (2021). Efficacy and safety of ramucirumab plus docetaxel in older patients with advanced non-small cell lung cancer: A multicenter retrospective cohort study. Journal of Geriatric Oncology. 13(2). 207–213. 4 indexed citations
9.
Kuroyama, Muneyoshi, et al.. (2020). A case of simultaneous occurrence of hepatitis and pancreatitis during the combination immunochemotherapy for non-small cell lung carcinoma. Respiratory Medicine Case Reports. 31. 101266–101266. 7 indexed citations
10.
Matsuno, Osamu, et al.. (2010). Deterioration of Asthma in a Patient With Diffuse Panbronchiolitis (DPB) After Macrolide Therapy. Journal of Asthma. 47(4). 486–488. 4 indexed citations
11.
Imamura, Fumio, Kiyonobu Ueno, Yoko Kusunoki, et al.. (2006). High-Dose-Rate Brachytherapy for Small-Sized Peripherally Located Lung Cancer. Strahlentherapie und Onkologie. 182(12). 703–707. 20 indexed citations
12.
Yoshimura, Mana, Fumio Imamura, Kiyonobu Ueno, & Junji Uchida. (2006). Gemcitabine/Carboplatin in a Modified 21-Day Administration Schedule for Advanced-Stage Non-Small-Cell Lung Cancer. Clinical Lung Cancer. 8(3). 208–213. 3 indexed citations
13.
Yamamoto, Suguru, Kiyonobu Ueno, Fumio Imamura, et al.. (2004). Usefulness of ultrathin bronchoscopy in diagnosis of lung cancer. Lung Cancer. 46(1). 43–48. 45 indexed citations
14.
Kawahara, Masaaki, Kyoichi Okishio, Shigeto Hosoe, et al.. (2002). Phase II study of weekly irinotecan and carboplatin for refractory or relapsed small-cell lung cancer. Lung Cancer. 37(3). 319–323. 36 indexed citations
15.
Ueno, Kiyonobu, Yoshikazu Inoue, Tomoya Kawaguchi, Shigeto Hosoe, & Masaaki Kawahara. (2001). Increased serum levels of basic fibroblast growth factor in lung cancer patients: relevance to response of therapy and prognosis. Lung Cancer. 31(2-3). 213–219. 46 indexed citations
16.
Kawaguchi, Tomoko, Kyoichi Okishio, Kiyonobu Ueno, et al.. (2000). [Autopsy case of adenoid cystic carcinoma of the trachea: endobronchial treatment improves quality of life].. PubMed. 38(10). 812–6. 1 indexed citations
17.
Minamoto, Seijiro, Kazuhiro Ikegame, Kiyonobu Ueno, et al.. (1997). Cloning and Functional Analysis of New Members of STAT Induced STAT Inhibitor (SSI) Family: SSI-2 and SSI-3. Biochemical and Biophysical Research Communications. 237(1). 79–83. 140 indexed citations
18.
Nakamura, Miho, et al.. (1996). [A case of allergic bronchopulmonary aspergillosis following active pulmonary tuberculosis].. PubMed. 45(11). 1181–4. 1 indexed citations
19.
Tachibana, Isao, Masahide Mori, Yoshiro Tanio, et al.. (1996). A 100-kDa Protein Tyrosine Phosphorylation Is Concurrent with β1 Integrin-Mediated Morphological Differentiation in Neuroblastoma and Small Cell Lung Cancer Cells. Experimental Cell Research. 227(2). 230–239. 9 indexed citations
20.
Hosoe, S, Kiyonobu Ueno, T Osaki, et al.. (1994). A frequent deletion of chromosome 5q21 in advanced small cell and non-small cell carcinoma of the lung.. PubMed. 54(7). 1787–90. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by М. К. Ибрагимова Breakdown of academic impact, for papers by Pedro Molina-Sánchez Breakdown of academic impact, for papers by Gerd Leder Breakdown of academic impact, for papers by F. Lerebours Breakdown of academic impact, for papers by Marianna Scrima Breakdown of academic impact, for papers by Yongdong Jiang Breakdown of academic impact, for papers by Sangeetha M. Reddy Breakdown of academic impact, for papers by Deborah Lehrer Breakdown of academic impact, for papers by Kristin Padavic Breakdown of academic impact, for papers by Steffen Wedel
Rankless by CCL
2026